Serán BioScience specializes in providing drug development and manufacturing services as a Contract Development and Manufacturing Organization (CDMO). They offer a variety of services, including preformulation, formulation development, dosage form development, spray drying, and particle engineering. Their operations adhere to current Good Manufacturing Practice (cGMP) standards, ensuring high quality and safety in their products through rigorous analytical quality control. Serán BioScience serves a wide range of clients, from small biotech startups to large pharmaceutical companies, and is distinguished by its flexibility in tailoring services to meet specific client needs. The company's goal is to enhance the efficiency and effectiveness of drug development processes for their clients.

Bain Capital Life Sciences

Vivo Capital

Biotechnology

Healthcare

Serán BioScience

Serán Bioscience announces $200 million strategic growth transaction and plans for new commercial facility.

Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility

With over 200 team members, including 150 scientists and engineers, Serán plans to add 150 more employees as part of its expansion.

Serán Bioscience Raises $200M for Strategic Expansion and New Commercial Facility

Serán Bioscience, a contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, analytical, and manufacturing services to pharmaceutical and biotechnology companies, has announced a strategic growth transaction of more than $200 million, which will support Serán's continued growth and construction of a new commercial-scale manufacturing facility.

Serán Bioscience Plans New Commercial-Scale Manufacturing Facility

"Politics, Patients, and Pharma" Image Credit: Nicole Bean for BioSpaceWhen prescription drug benefits were added to Medicare via the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the government was not given the ability to negotiate drug pricing. As a result, pharmaceutical companies were, and are, able to determine their own pricing. Another result is that prices for prescription drugs are higher in the U.S., significantly higher, than in most other developed countries.In a 2021 study conducted by the RAND Corporation, researchers estimated that U.S. drug prices were an average 2.56 times higher than the other 32 countries in the Organization for Economic Co-operation and Development (OECD). The gap increases to 3.44 times higher for larger brand-name drugs.Balancing Innovation, Pricing  PatientsBoth the government and the pharma industry seek to give patients access to medications that enhance their quality of life. The question is how to achieve this without putting financial burdens on these patients

The Ira: A Catalyst For Societal Change

Serán is partnering with Oregon Bioscience Association ( oregonbio.org ) to establish a state-sponsored apprenticeship program with the goal of providing paid employment and education to entry-level operations and laboratory technicians.

Serán Bioscience Breaks Ground on Additional cGMP Manufacturing Capacity at its Bend Site

Contract development and manufacturing for pharmaceuticals

Serán BioScience

Contract development and manufacturing for pharmaceuticals

Serán BioScience

Contract development and manufacturing for pharmaceuticals

About

Simplify's Take

What believers are saying

What critics are saying

What makes Serán BioScience unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Serán BioScience is Hiring for 0 Jobs on Simplify!